DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neoral (Cyclosporine) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Neoral (Cyclosporine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (395)
     Blood Creatinine Increased (76)Pyrexia (46)Nephropathy Toxic (36)more >>

Cases resulting in a serious event (390)
     Blood Creatinine Increased (75)Pyrexia (46)Nephropathy Toxic (34)more >>

Cases resulting in death (76)
     Thrombotic Microangiopathy (13)Disease Progression (12)Diarrhoea (11)more >>

Cases resulting in life threatening events (34)
     Vomiting (6)Pyrexia (5)Renal Failure (5)more >>

Cases resulting in hospitalization (252)
     Blood Creatinine Increased (55)Pyrexia (36)Renal Impairment (30)more >>

Cases resulting in disability (31)
     Proteinuria (8)Headache (7)Blood Creatinine Increased (7)more >>

Cases resulting in other serious reactions (195)
     Blood Creatinine Increased (36)Pyrexia (21)Nephropathy Toxic (20)more >>

Below is a sample of reports where side effects / adverse reactions may be related to Neoral (Cyclosporine). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in 62 year old female receiving Neoral (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-31

Patient: 62 year old female

Adverse reactions / side effects: Bronchopulmonary Aspergillosis, Cardiac Failure, Fungus Serology Test Positive

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Azathioprine
    Administration route: Oral
    Indication: Systemic Lupus Erythematosus

Neoral
    Administration route: Oral
    Indication: Systemic Lupus Erythematosus

Prednisolone
    Administration route: Oral
    Indication: Systemic Lupus Erythematosus



Adverse event in 38 year old male receiving Neoral (Cyclosporine)

Reported by a physician from Turkey on 2007-10-30

Patient: 38 year old male, weighing 83.0 kg (182.6 pounds)

Adverse reactions / side effects: Vomiting, Nausea, Diarrhoea, Gastroenteritis, Pyrexia

Adverse event resulted in: hospitalization

Suspect drug(s):
Certican
    Dosage: 0.75 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2006-07-04
    End date: 2007-09-10

Certican
    Dosage: 0.75 mg/daily
    Administration route: Oral
    Start date: 2007-09-10

Neoral
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2006-07-04

Other drugs received by patient: Methylprednisolone



Adverse event in 32 year old female receiving Neoral (Cyclosporine)

Reported by a physician from Turkey on 2007-10-30

Patient: 32 year old female, weighing 57.6 kg (126.7 pounds)

Adverse reactions / side effects: Tubulointerstitial Nephritis, Complications of Transplanted Kidney, Escherichia Urinary Tract Infection, Headache, Pyrexia, Dysuria, Graft Infection, Blood Creatinine Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Certican
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-01-16

Neoral
    Dosage: 100 mg/daily
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-01-17



Adverse event in 25 year old female receiving Neoral (Cyclosporine)

Reported by a physician from Japan on 2007-10-30

Patient: 25 year old female, weighing 52.0 kg (114.4 pounds)

Adverse reactions / side effects: Subarachnoid Haemorrhage, Herpes Zoster

Adverse event resulted in: hospitalization

Suspect drug(s):
Campath
    Dosage: 8.3 mg, 1x/day
    Indication: Allogenic Bone Marrow Transplantation Therapy
    Start date: 2007-05-04
    End date: 2007-05-09

Neoral
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2007-06-28

Other drugs received by patient: Fludara; Endoxan; Zovirax; Cravit; Diflucan; Sandimmune; Solu-Medrol; Polaramine; Marzulene S; Loxonin; Adalat; Baktar; Itrizole; Foliamin



Adverse event in 56 year old male receiving Neoral (Cyclosporine)

Reported by a physician from United Kingdom on 2007-10-29

Patient: 56 year old male

Adverse reactions / side effects: Skin Ulcer, Wound Debridement

Adverse event resulted in: hospitalization

Suspect drug(s):
Mycophenolate Mofetil
    Dosage: 500 mg, bid
    Administration route: Oral
    Start date: 2005-07-18

Neoral
    Dosage: 150 mg, bid
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2005-07-08

Other drugs received by patient: Metoprolol; Prednisone; Omeprazole; Simvastatin; Alendronic Acid; Aspirin; Insulin



Adverse event in 10 year old male receiving Neoral (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-29

Patient: 10 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Blood Urea Increased, Headache, Superior Sagittal Sinus Thrombosis, Nephrotic Syndrome, Convulsion, Cerebral Infarction, Dehydration, Proteinuria, Oliguria, Oedema, Blood Creatinine Increased, Acute Prerenal Failure, Anuria, Influenza

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Acecol
    Dosage: 2 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome
    End date: 2007-03-01

Bredinin
    Dosage: 150 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome

Diovan
    Dosage: 80 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome
    End date: 2007-03-01

Neoral
    Dosage: 140 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome
    End date: 2007-03-19

Predonine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome

Other drugs received by patient: Lipitor; Zyloric



Adverse event in 10 year old male receiving Neoral (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-29

Patient: 10 year old male, weighing 60.0 kg (132.0 pounds)

Adverse reactions / side effects: Blood Urea Increased, Headache, Superior Sagittal Sinus Thrombosis, Nephrotic Syndrome, Convulsion, Cerebral Infarction, Dehydration, Proteinuria, Oliguria, Oedema, Blood Creatinine Increased, Acute Prerenal Failure, Anuria, Influenza

Adverse event resulted in: hospitalization, disablity

Suspect drug(s):
Acecol
    Dosage: 2 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome
    End date: 2007-03-01

Bredinin
    Dosage: 150 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome

Diovan
    Dosage: 80 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome
    End date: 2007-03-01

Neoral
    Dosage: 140 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome
    End date: 2007-03-19

Predonine
    Dosage: 40 mg/d
    Administration route: Oral
    Indication: Nephrotic Syndrome

Other drugs received by patient: Lipitor; Zyloric



Adverse event in 33 year old male receiving Neoral (Cyclosporine)

Reported by a physician from Malaysia on 2007-10-29

Patient: 33 year old male

Adverse reactions / side effects: Intra-Abdominal Haemorrhage, Hypovolaemic Shock, Multi-Organ Failure, Sepsis, Explorative Laparotomy

Adverse event resulted in: death, life threatening event, hospitalization

Suspect drug(s):
Certican
    Dosage: no treatment
    Indication: Renal Transplant

Myfortic
    Indication: Renal Transplant

Neoral
    Indication: Renal Transplant

Other drugs received by patient: Prednisolone



Adverse event in 46 year old female receiving Neoral (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-29

Patient: 46 year old female

Adverse reactions / side effects: Cytomegalovirus Antigen Positive, Haptoglobin Decreased, RED Blood Cell Abnormality, Proteinuria, Blood Lactate Dehydrogenase Increased, Thrombotic Microangiopathy, Focal Glomerulosclerosis

Adverse event resulted in: disablity

Suspect drug(s):
Cyclophosphamide

Neoral
    Dosage: unk, unk
    Administration route: Oral
    Indication: Allogenic Bone Marrow Transplantation Therapy
    End date: 2007-03-22

Sandimmune
    Dosage: 3 mg/kg/day
    Indication: Allogenic Bone Marrow Transplantation Therapy
    Start date: 2006-12-12

Other drugs received by patient: Methotrexate; Campath; Fludarabine Phosphate



Adverse event in 46 year old female receiving Neoral (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-29

Patient: 46 year old female

Adverse reactions / side effects: Cytomegalovirus Antigen Positive, Haptoglobin Decreased, RED Blood Cell Abnormality, Proteinuria, Blood Lactate Dehydrogenase Increased, Thrombotic Microangiopathy, Focal Glomerulosclerosis

Adverse event resulted in: disablity

Suspect drug(s):
Cyclophosphamide

Neoral
    Dosage: unk, unk
    Administration route: Oral
    Indication: Allogenic Bone Marrow Transplantation Therapy
    End date: 2007-03-22

Sandimmune
    Dosage: 3 mg/kg/day
    Indication: Allogenic Bone Marrow Transplantation Therapy
    Start date: 2006-12-12

Other drugs received by patient: Methotrexate; Campath; Fludarabine Phosphate



Adverse event in 27 year old male receiving Neoral (Cyclosporine)

Reported by a physician from United States on 2007-10-29

Patient: 27 year old male, weighing 75.7 kg (166.5 pounds)

Adverse reactions / side effects: Pneumonia Aspiration, Graft Thrombosis, Nephropathy Toxic, Abdominal Distension, Blood Creatinine Increased, Hypertension, Leukopenia

Adverse event resulted in: hospitalization

Suspect drug(s):
Certican
    Dosage: 0.75 mg, q12h
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-04-18
    End date: 2007-05-03

Neoral
    Administration route: Oral
    Indication: Renal Transplant



Adverse event in male receiving Neoral (Cyclosporine)

Reported by a pharmacist from Ireland on 2007-10-26

Patient: male

Adverse reactions / side effects: Dysarthria, Condition Aggravated

Suspect drug(s):
Neoral (Cyclosporine)



Adverse event in 46 year old female receiving Neoral (Cyclosporine)

Reported by a physician from United States on 2007-10-25

Patient: 46 year old female

Adverse reactions / side effects: Small Intestinal Obstruction, Vomiting, Nausea, Clostridial Infection, Abdominal Pain Upper

Adverse event resulted in: hospitalization

Suspect drug(s):
Cellcept
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-04-26
    End date: 2007-06-15

Neoral
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-04-30

Other drugs received by patient: Medrol; Protonix; Ganciclovir; Acetylsalicylic Acid SRT; Bactrim; Phenergan HCL



Adverse event in 43 year old male receiving Neoral (Cyclosporine)

Reported by a physician from Germany on 2007-10-22

Patient: 43 year old male, weighing 99.0 kg (217.8 pounds)

Adverse reactions / side effects: Pulmonary Hypertension, Atrioventricular Block Second Degree, Drug Level Above Therapeutic, Dyspnoea Exertional, C-Reactive Protein Increased, Pharyngolaryngeal Pain, Vertigo, Bradycardia, Infection

Adverse event resulted in: hospitalization

Suspect drug(s):
Certican
    Dosage: 2000 mg / day
    Administration route: Oral
    Indication: Lung Transplant
    Start date: 2006-10-06

Dilzem

Neoral
    Indication: Lung Transplant



Adverse event in 53 year old male receiving Neoral (Cyclosporine)

Reported by a physician from United Kingdom on 2007-10-22

Patient: 53 year old male, weighing 96.0 kg (211.2 pounds)

Adverse reactions / side effects: Dyspnoea, Renal Impairment, Blood Creatinine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Mycophenolate Mofetil
    Dosage: 1.5 mg, bid
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2007-04-14

Neoral
    Dosage: 175 mg daily
    Administration route: Oral
    Indication: Heart Transplant
    Start date: 2007-04-14



Adverse event in 26 year old male receiving Neoral (Cyclosporine)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient: 26 year old male

Adverse reactions / side effects: RED Blood Cell Schistocytes Present, Urine Output Decreased, Blood Lactate Dehydrogenase Increased, Liver Function Test Abnormal, Platelet Count Decreased, Haemolytic Uraemic Syndrome, Blood Creatinine Increased

Suspect drug(s):
Neoral (Cyclosporine)

Other drugs received by patient: Mycophenolate Mofetil; Prednisolone; Pantoprazole Sodium



Adverse event in 58 year old male receiving Neoral (Cyclosporine)

Reported by a physician from Italy on 2007-10-22

Patient: 58 year old male, weighing 102.0 kg (224.4 pounds)

Adverse reactions / side effects: Bacterial Sepsis, Fungal Sepsis, Graft Ischaemia, Concomitant Disease Progression, Cerebral Haemorrhage, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Neoral
    Dosage: 790 mg/daily
    Administration route: Oral
    Indication: Liver Transplant
    Start date: 2007-08-15

Neoral
    Dosage: 1590 mg/daily
    Administration route: Oral
    Start date: 2007-08-16
    End date: 2007-08-17

Other drugs received by patient: Methylprednisolone



Adverse event in 28 year old male receiving Neoral (Cyclosporine)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-22

Patient: 28 year old male, weighing 53.0 kg (116.6 pounds)

Adverse reactions / side effects: Stomatitis, Alanine Aminotransferase Increased, Mouth Ulceration, Pyrexia, Liver Disorder, Eating Disorder, Herpes Simplex Serology Positive, Hepatitis Viral, Oral Pain, Aspartate Aminotransferase Increased, Bronchitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Amn107
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    Start date: 2006-05-09
    End date: 2006-06-19

Amn107
    Dosage: 400 mg
    Administration route: Oral
    Start date: 2006-06-20
    End date: 2006-07-03

Amn107
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2006-07-18
    End date: 2006-07-21

Amn107
    Dosage: 400 mg, bid
    Administration route: Oral
    Start date: 2006-07-04
    End date: 2006-07-17

Neoral
    Indication: Unrelated Donor Bone Marrow Transplantation Therapy

Other drugs received by patient: Loxonin; Selbex; Negmin; Urso 250; Flomox; Dasen; Asverin; Hachiazule; Indomethacin; Levofloxacin; Veen D; Solita T



Adverse event in 28 year old male receiving Neoral (Cyclosporine)

Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-22

Patient: 28 year old male, weighing 53.0 kg (116.6 pounds)

Adverse reactions / side effects: Stomatitis, Alanine Aminotransferase Increased, Mouth Ulceration, Encephalitis, Device Related Infection, Pyrexia, Eating Disorder, Liver Disorder, Hepatitis Viral, Herpes Simplex Serology Positive, Oral Pain, Meningitis Fungal, Aspartate Aminotransferase Increased, Bronchitis

Adverse event resulted in: hospitalization

Suspect drug(s):
Amn107
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    Start date: 2006-05-09
    End date: 2006-06-19

Amn107
    Dosage: 400 mg
    Administration route: Oral
    Start date: 2006-06-20
    End date: 2006-07-03

Amn107
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2006-07-18
    End date: 2006-07-21

Amn107
    Dosage: 400 mg, bid
    Administration route: Oral
    Start date: 2006-07-04
    End date: 2006-07-17

Neoral
    Indication: Unrelated Donor Bone Marrow Transplantation Therapy

Other drugs received by patient: Loxonin; Selbex; Negmin; Urso 250; Flomox; Dasen; Asverin; Hachiazule; Indomethacin; Levofloxacin; Veen D; Solita T



Adverse event in 26 year old male receiving Neoral (Cyclosporine)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient: 26 year old male

Adverse reactions / side effects: RED Blood Cell Schistocytes Present, Urine Output Decreased, Blood Lactate Dehydrogenase Increased, Liver Function Test Abnormal, Platelet Count Decreased, Haemolytic Uraemic Syndrome, Blood Creatinine Increased

Suspect drug(s):
Neoral (Cyclosporine)

Other drugs received by patient: Mycophenolate Mofetil; Prednisolone; Pantoprazole Sodium



Adverse event in 46 year old female receiving Neoral (Cyclosporine)

Reported by a individual with unspecified qualification from United States on 2007-10-22

Patient: 46 year old female

Adverse reactions / side effects: Small Intestinal Obstruction, Vomiting, Nausea, Clostridial Infection, Abdominal Pain Upper, Gastritis

Adverse event resulted in: hospitalization

Suspect drug(s):
Cellcept
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-04-26
    End date: 2007-06-15

Neoral
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2007-04-30

Other drugs received by patient: Sirolimus; Azathioprine; Methylprednisolone; Pantoprazole Sodium; Acetylsalicylic Acid; Sulfamethoxazole / Trimethoprim ^dak^; Promethazine HCL; Ganciclovir



Adverse event in 26 year old male receiving Neoral (Cyclosporine)

Reported by a consumer/non-health professional from United States on 2007-10-19

Patient: 26 year old male

Adverse reactions / side effects: RED Blood Cell Schistocytes Present, Urine Output Decreased, Blood Lactate Dehydrogenase Increased, Liver Function Test Abnormal, Platelet Count Decreased, Haemolytic Uraemic Syndrome, Blood Creatinine Increased

Suspect drug(s):
Neoral (Cyclosporine)

Other drugs received by patient: Mycophenolate Mofetil; Prednisolone; Pantoprazole Sodium



Adverse event in 46 year old male receiving Neoral (Cyclosporine)

Reported by a physician from Spain on 2007-10-19

Patient: 46 year old male, weighing 67.0 kg (147.4 pounds)

Adverse reactions / side effects: Renal Impairment, Enterococcal Infection, Urosepsis, Pyrexia

Adverse event resulted in: hospitalization

Suspect drug(s):
Certican
    Dosage: 2.5mg daily
    Administration route: Oral
    Indication: Renal Transplant
    Start date: 2006-06-06
    End date: 2006-08-16

Neoral
    Indication: Renal Transplant

Steroids NOS

Urbason



Adverse event in 54 year old male receiving Neoral (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-18

Patient: 54 year old male, weighing 55.0 kg (121.0 pounds)

Adverse reactions / side effects: Protein Urine Present, Renal Disorder, Graft Versus Host Disease, Nephropathy Toxic, Skin Disorder, Rash, Glomerulonephritis Membranous, Hepatocellular Damage, Nephrotic Syndrome, Hypoaesthesia Oral, Blood Creatinine Increased

Suspect drug(s):
Neoral
    Dosage: 300 mg/d
    Administration route: Oral
    Indication: Bone Marrow Transplant
    Start date: 2005-07-06
    End date: 2005-07-19

Neoral
    Dosage: 100 mg/d
    Administration route: Oral
    Start date: 2005-07-20
    End date: 2005-08-29

Neoral
    Dosage: 150 mg/d
    Administration route: Oral
    Start date: 2005-08-30
    End date: 2005-09-05

Neoral
    Dosage: 100 mg/d
    Administration route: Oral
    Start date: 2005-09-06
    End date: 2005-09-19

Neoral
    Dosage: 80 mg/d
    Administration route: Oral
    Start date: 2005-09-20
    End date: 2005-09-26

Neoral
    Dosage: 70 mg/d
    Administration route: Oral
    Start date: 2005-09-27
    End date: 2005-10-03

Neoral
    Dosage: 60 mg/d
    Administration route: Oral
    Start date: 2005-10-04
    End date: 2005-10-10

Neoral
    Dosage: 50 mg/d
    Administration route: Oral
    Start date: 2005-10-11
    End date: 2005-11-07

Neoral
    Dosage: 10 mg/d
    Administration route: Oral
    Start date: 2005-11-08
    End date: 2005-11-14

Neoral
    Dosage: 20 mg/d
    Administration route: Oral
    Start date: 2005-11-15
    End date: 2005-11-21

Neoral
    Dosage: 40 mg/d
    Administration route: Oral
    Start date: 2005-11-22
    End date: 2005-12-19

Neoral
    Dosage: 140 mg/d
    Administration route: Oral
    Start date: 2005-12-20
    End date: 2006-01-18

Neoral
    Dosage: 120 mg/d
    Administration route: Oral
    Start date: 2006-01-19
    End date: 2006-02-20

Neoral
    Dosage: 80 mg/d
    Administration route: Oral
    Start date: 2006-02-21
    End date: 2006-03-27

Neoral
    Dosage: 50 mg/d
    Administration route: Oral
    Start date: 2006-03-28
    End date: 2006-04-10

Neoral
    Dosage: 40 mg/d
    Administration route: Oral
    Start date: 2006-04-11
    End date: 2006-05-22

Neoral
    Dosage: 30 mg/d
    Administration route: Oral
    Start date: 2006-05-23
    End date: 2006-06-12

Neoral
    Dosage: 10 mg/d
    Administration route: Oral
    Start date: 2006-06-13
    End date: 2006-07-24

Neoral
    Dosage: 40 mg/d
    Administration route: Oral
    Start date: 2006-07-25
    End date: 2006-08-21

Neoral
    Dosage: 75 - 50 mg/d
    Administration route: Oral
    Start date: 2006-08-22

Other drugs received by patient: Sandimmune



Adverse event in 1 year old male receiving Neoral (Cyclosporine)

Reported by a individual with unspecified qualification from Japan on 2007-10-17

Patient: 1 year old male, weighing 8.5 kg (18.7 pounds)

Adverse reactions / side effects: Stem Cell Transplant, Immunosuppressant Drug Level Decreased, Acute Graft Versus Host Disease, Acute Myeloid Leukaemia Recurrent

Adverse event resulted in: death

Suspect drug(s):
Neoral
    Dosage: unk, unk
    Administration route: Oral
    Indication: Bone Marrow Transplant
    End date: 2003-08-14

Sandimmune
    Dosage: 1.5 mg/kg
    Indication: Bone Marrow Transplant

Other drugs received by patient: Methotrexate; Endoxan

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009